RNACCartesian Therapeutics Inc. Common Stock
10.04USD-4.29%Mkt Cap: 303.76M $P/E: —3d ago
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company's lead product candidate is Descartes-08, an autologous mRNA chimer…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap303.76M $
Enterprise Value225.76M $
Revenue (TTM)1.48M $
Gross Profit-66.91M $
Net Income (TTM)-130.30M $
Revenue/Share0.0550 USD
Last Price10.04 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.69
PEG—
EV/EBITDA-2.35
EV/Revenue152.85
P/S209.55
P/B-2.45
EPS (TTM)-5.78
EPS (Forward)-3.81
52W Range
5.60072% of range11.80
52W High11.80 USD
52W Low5.600 USD
Profitability
Gross Margin0.00%
Oper. Margin-6679.69%
EBITDA Margin0.00%
Profit Margin-4658.63%
ROE103.22%
ROA-43.96%
Growth
Revenue Growth—
Earnings Growth-8.00%
Cash Flow & Leverage
Operating CF-73.94M $
CapEx (TTM)5.45M $
FCF Margin-3214.65%
FCF Yield-15.63%
Net Debt-83.75M $
Net Debt/EBITDA0.87
Balance Sheet
Debt/Equity-0.10
Current Ratio7.47
Quick Ratio7.19
Book Value/Sh-4.1690 USD
Cash/Share4.879 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateApr 5, 2024
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)34.57 USD
Upside (mean)+244.3%
Target Range16.00 USD – 44.00 USD
$16.00+244.3% to mean$44.00
# Analysts7
Ownership
Shares Out.30.26M
Float11.49M
Insiders52.13%
Institutions29.46%
Short Interest
Short Ratio11.7d
Short % Float13.29%
Short % Out.6.09%
Shares Short1.84M
Short (prev mo.)1.89M
Technical
SMA 508.932 (+12.4%)
SMA 2007.563 (+32.8%)
Beta0.56
S&P 52W Chg18.16%
Avg Vol (30d)136.91K
Avg Vol (10d)129.68K
Technical Indicators
RSI (14)66.6
MACD0.3179
MACD Signal0.0937
MACD Hist.+0.2243
BB Upper10.06 USD
BB Middle8.469 USD
BB Lower6.876 USD
BB Width37.61%
ATR (14)0.6184 USD
Vol Ratio (20d)1.26x